ROSSMAX (4121.TWO) monthly revenue, September 2026

ROSSMAX reported revenue of NT$0.33bn for September 2026, down 1.1% from the previous month and up 9.2% from a year earlier. Year-to-date revenue was NT$2.87bn, up 0.8% year on year. It ranked 82 of 159 companies in the Biotechnology and Medical Care industry by year-on-year growth.

中文版

MonthRevenue NT$bnMoM %YoY %
September 20260.33-1.19.2